HF
CEROW

HRT Financial’s CERo Therapeutics Warrants CEROW Stock Holding History

HRT Financial’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,788
Closed – – 3263
2024
Q2 		$0 Sell
35,788
-212
-0.6% -$12 ﹤0.01% 3259
2024
Q1 		$3K Sell
36,000
-296
-0.8% -$18 ﹤0.01% 2137
2023
Q4 		$0 Buy
36,296
+296
+0.8% +$9 ﹤0.01% 3198
2023
Q3 		$2K Sell
36,000
-340
-0.9% -$24 ﹤0.01% 2245
2023
Q2 		$2K Buy
36,340
+340
+0.9% +$15 ﹤0.01% 2291
2023
Q1 		$1K Hold
36,000
– – ﹤0.01% 2380
2022
Q4 		$1K Hold
36,000
– – ﹤0.01% 2377
2022
Q3 		$5K Hold
36,000
– – ﹤0.01% 2594
2022
Q2 		$3K Hold
36,000
– – ﹤0.01% 2779
2022
Q1 		$6K Hold
36,000
– – ﹤0.01% 2943
2021
Q4 		$15K Buy
+36,000
New +$16.6K ﹤0.01% 2986

Other funds holding CEROW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

HRT Financial's CEROW Position: Q3 2024 in Review

HRT Financial sold out of CERo Therapeutics Warrants (CEROW) in Q3 2024, closing a stake of 35,788 shares.

HRT Financial first reported a position in CEROW in Q4 2021 and held it in 11 quarters. The position peaked at $15K in Q4 2021. 30 funds tracked by Wall St. Rank hold CEROW as of Q3 2024.

  • HRT Financial reported no remaining CERo Therapeutics Warrants position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 35,788 CERo Therapeutics Warrants shares in Q3 2024.
  • HRT Financial first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 11 quarters.
  • HRT Financial's CERo Therapeutics Warrants position peaked at $15K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.